ESG

Kincell Bio and RegCell partner to bring a groundbreaking, non-gene-edited Treg cell therapy for autoimmune diseases from the lab to clinical trials.

With a new CEO and stunning clinical data, BOOST Pharma advances a potential game-changer for children with the rare genetic disorder Osteogenesis Imperfecta.

Commercial real estate values rose for a sixth straight quarter, yet a stark divide between thriving industrial and lagging office sectors redefines the market.

Lithuanian manufacturer Eurodita's 'no minimum order' private-label plan could reshape Europe's construction market for independent dealers.

Aardvark Therapeutics is expanding its Phase 3 trial for a novel Prader-Willi Syndrome drug to include children as young as seven, targeting a key unmet need.

Ahead of its first Climate Week, Mumbai's food innovators and activists gather to debate a sustainable future, proving the fight for the planet begins on our plates.

Amid major restructuring and a strategic asset sale, Standard BioTools' upcoming annual results will reveal its progress toward profitability in a tough market.

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

FPX Nickel's massive Baptiste project could supply low-carbon nickel for EVs, but it first needs to win over the public and regulators. Here's what's at stake.

A new framework from LatticeFlow AI and Unique AI translates Swiss financial regulations into auditable code, paving the way for safer AI in banking.

Israeli startup Protai is set to reveal promising preclinical data for its cancer drug, PRT-001, powered by its unique proteomics-aware AI platform.

Celebrating 30 years, Topband's journey from a local supplier to a global intelligent solutions giant mirrors China's industrial evolution.

A new partnership between South Korea's GCCL and Europe's Medicover MICS promises to streamline drug development by creating a seamless East-West axis.

OPEX Corporation launches the Velo Series, powered by InoTec, challenging market leaders with scanners designed for every scale of digital transformation.

Two tech giants unite to extend AI beyond the data center, promising a faster, greener, and more accessible future for artificial intelligence.

As XRP's path to $10 remains a long-term goal, investors are eyeing early-stage projects like Pepeto, a 'meme-utility' that has raised over $7M.

A new partnership allows FranklinWH battery owners to join Origin's VPP, unlocking new earnings while setting a new industry standard for warranty protection.

Following a landmark FDA approval, IceCure Medical's long-serving CFO is exiting, placing the company at a pivotal financial crossroads for its new treatment.

The BDC generated a robust 12.52% yield, but a $7.2M unrealized loss in equities pulled down its net asset value, painting a complex picture.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.